Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: GAUSS-3 Trial

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: GAUSS-3 Trial

By Cleveland Clinic Heart, Vascular and Thoracic Institute FEATURING Steven Nissen

520 views

July 26, 2016

Dr. Steve Nissen discusses the results and clinical implications of the GAUSS 3 Trial, presented ...
read more ↘ at ACC.16, a trial designed to confirm statin-induced muscle intolerance and determine if alternative drug therapies provide better options for treatment
↖ read less

0 Comments